You can see how this Live Attenuated Virus vaccine works. or contuniue on to another strategy.
You will have to culture the virus in a special lab environment designed to give them a hard time replicating, and eventually become weakened. Then, you inject these attenuated viruses into a human subject.
You can check out the process in institutions that have developed vaccines using Live Attenuated Virus.
The Indian Immunologicals Limited, Griffith University and Serum Institute of India are developing vaccines using this strategy.
The problem is, by the end of June 2020, their vaccine candidates were still in a preclinical phase.
You can keep on going with the Live Attenuated Virus or change your mind and select a different strategy.
You may opt to collaborate with India or develop vaccine on your own.
Whoops, we don’t have a cooperation agreement with India yet.
You can propose for such cooperation Remember though, time is not on your side.
Very well, if you think so. You must first request partnership with India. Your biggest hurdle is that their vaccine candidates are currently still in a preclinical stage, so they will likely need more than a year to be ready. Live Attenuated Vaccine is effective, but this carries its own risks when used to make vaccines of SARS-CoV2, a virus which we still don’t know much about.
Try a diffrent strategy.
Who wants to make a vaccine? No institution in Indonesia is yet ready to develop one.
You can still develop a vaccine on your own or adopt the collaborate with India. approach.
There are biomedicine institutions in Indonesia capable of developing vaccine using Live Attenuated Virus. The problem is, they currently have no plan of doing so. You will have to lobby them, and this takes time. Even then they will have to start the research from scratch.
Try to take a look at a different strategy. or collaborate with India.
